Product NewsInexpensive drug, Fluvoxamine, confirmed as a COVID-19 treatment using Cytel-designed platform trial
Expert InsightsIncreased cellular avidity upon combining multi-targeting and co-stimulation leads to enhanced CAR-T cell sensitivity and persistence